Entercef-CV 625 is a powerful β-lactam/β-lactamase inhibitor combination designed to overcome resistant bacterial infections. Cefuroxime delivers broad-spectrum bactericidal action, while Clavulanate protects it from β-lactamase degradation—ensuring enhanced efficacy in difficult-to-treat infections.